Article
Tissue and Sex-Specific Performance of a Cancer Driver Based Biomarker in rasH2-Tg Mice.
Environmental and molecular mutagenesis - 1 Oct 2025
Harris Kelly L, Faske Jennifer B, Gong Binsheng, Parsons Barbara L
Abstract excerpt
The ability to predict rodent lifetime tumor responses from short-term exposures and a scientific basis for rodent to human extrapolation are unmet needs in cancer risk assessment. To address these needs, quantitation of cancer driver mutations (CDMs) was integrated with an error-corrected, next generation sequencing (NGS) approach. The method developed, CarcSeq, involves performing multiple, high-fidelity PCR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
